Pharmaceutics (Dec 2022)

Photodynamic Therapy as an Effective Treatment for Cutaneous Lymphomas

  • Stefano Caccavale,
  • Vittorio Tancredi,
  • Paola Vitiello,
  • Antonello Sica,
  • Andrea Ronchi,
  • Renato Franco,
  • Francesco Pastore,
  • Giuseppe Argenziano

DOI
https://doi.org/10.3390/pharmaceutics15010047
Journal volume & issue
Vol. 15, no. 1
p. 47

Abstract

Read online

Topical photodynamic therapy (PDT) is a non-invasive treatment modality frequently used in dermatology to treat superficial skin cancers but also some inflammatory or infectious dermatoses. PDT appears a more and more promising therapeutic option also for cutaneous lymphomas, either of T- or B-cell origin. It is a well-tolerated treatment and has excellent cosmetic outcomes, less side effects compared to other therapies (steroids, surgery, radiotherapy, and so on), no particular contraindications, and is easily repeatable in case of relapses. However, how PDT works in the treatment of cutaneous lymphoproliferative diseases is poorly understood and the literature data are still controversial. Further randomized, controlled clinical trials involving a greater number of patients and centers with a long follow-up are necessary to assess the efficacy of PDT and establish a unique standardized treatment protocol in relation to the lymphomatous disease and the type, thickness, and location of the lesions.

Keywords